Literature DB >> 20079887

Effects of congenital cataract mutation R116H on alphaA-crystallin structure, function and stability.

Min Pang1, Jing-Tan Su, Shan Feng, Zhi-Wei Tang, Feng Gu, Meng Zhang, Xu Ma, Yong-Bin Yan.   

Abstract

alpha-crystallin is a molecular chaperone that maintains the optical properties of the lens and delays the onset scattering caused by aging-related protein aggregation. In this research, we found that the missense mutation R116H resulted in an altered size distribution, impaired packing of the secondary structures and modified quaternary structure with great hydrophobic exposure. The mutant exhibited a substrate-dependent chaperone (aggregation-inhibition) or anti-chaperone (aggregation-promotion) effect. Equilibrium unfolding experiments indicated that the mutation stabilized an aggregation-prone intermediate which was not populated during the unfolding of the wild-type protein. The accumulation of this intermediate greatly promoted the formation of non-native large oligomers or aggregates during unfolding. These results suggested that both the aggregation of the mutant upon stress and co-deposition with the target proteins were likely to be responsible for the onset of cataract. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20079887     DOI: 10.1016/j.bbapap.2010.01.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

1.  Novel Mutations in the Crystallin Gene in Age-Related Cataract Patients from a North Indian Population.

Authors:  Rashmi Patel; Ravish K Zenith; Abhishek Chandra; Akhtar Ali
Journal:  Mol Syndromol       Date:  2017-04-26

Review 2.  Differential role of arginine mutations on the structure and functions of α-crystallin.

Authors:  Alok Kumar Panda; Sandip Kumar Nandi; Ayon Chakraborty; Ram H Nagaraj; Ashis Biswas
Journal:  Biochim Biophys Acta       Date:  2015-06-14

3.  Temperature-dependent structural and functional properties of a mutant (F71L) αA-crystallin: molecular basis for early onset of age-related cataract.

Authors:  Vakdevi Validandi; V Sudhakar Reddy; P N B S Srinivas; Niklaus H Mueller; S G Bhagyalaxmi; T Padma; J Mark Petrash; G Bhanuprakash Reddy
Journal:  FEBS Lett       Date:  2011-11-11       Impact factor: 4.124

4.  Cataract-causing αAG98R-crystallin mutant dissociates into monomers having chaperone activity.

Authors:  Murugesan Raju; Puttur Santhoshkumar; K Krishna Sharma
Journal:  Mol Vis       Date:  2011-01-05       Impact factor: 2.367

5.  Impact of the 237th residue on the folding of human carbonic anhydrase II.

Authors:  Ming-Jie Wu; Yan Jiang; Yong-Bin Yan
Journal:  Int J Mol Sci       Date:  2011-04-28       Impact factor: 5.923

6.  The congenital cataract-linked A2V mutation impairs tetramer formation and promotes aggregation of βB2-crystallin.

Authors:  Jia Xu; Sha Wang; Wei-Jie Zhao; Yi-Bo Xi; Yong-Bin Yan; Ke Yao
Journal:  PLoS One       Date:  2012-12-06       Impact factor: 3.240

7.  A novel CRYGD mutation (p.Trp43Arg) causing autosomal dominant congenital cataract in a Chinese family.

Authors:  Binbin Wang; Changhong Yu; Yi-Bo Xi; Hong-Chen Cai; Jing Wang; Sirui Zhou; Shiyi Zhou; Yi Wu; Yong-Bin Yan; Xu Ma; Lixin Xie
Journal:  Hum Mutat       Date:  2011-01       Impact factor: 4.878

8.  The congenital cataract-linked G61C mutation destabilizes γD-crystallin and promotes non-native aggregation.

Authors:  Wang Zhang; Hong-Chen Cai; Fei-Feng Li; Yi-Bo Xi; Xu Ma; Yong-Bin Yan
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

9.  Congenital anterior polar cataract associated with a missense mutation in the human alpha crystallin gene CRYAA.

Authors:  Lu Zhang; Yi Zhang; Ping Liu; Wenping Cao; Xianling Tang; Sheng Su
Journal:  Mol Vis       Date:  2011-10-15       Impact factor: 2.367

10.  Patterns of gene expression in microarrays and expressed sequence tags from normal and cataractous lenses.

Authors:  Konstantinos Sousounis; Panagiotis A Tsonis
Journal:  Hum Genomics       Date:  2012-09-01       Impact factor: 4.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.